Clinical Trial Update: Comparison of a Novel 22-gauge Core Biopsy Needle [NA]

View source ↗

Summary

Completed clinical trial comparing a novel 22-gauge core biopsy needle; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasm of Pancreas
• Solid Pancreatic Mass Lesions

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Solid Pancreatic Mass Lesions, Malignant Neoplasm of Pancreas | NA | Status: COMPLETED | Results posted: 2018-12-27